Schistosomiasis, HIV and women - the role of the cervicovaginal environment and STI co-infection

3 February 2022, 5.00 PM - 3 February 2022, 6.00 PM

Dr Amy Sturt (Veteran's Affairs Health Care System, Palo Alto)

Hosted by the STI Research Interest Group based at the London School of Hygiene and Tropical Medicine

This seminar examines vaginal inflammation, STI co-infection, and the cervicovaginal microbiota as potential co-factors in the association of genital schistosomiasis with HIV-1. 

Between one-third to three-fourths of girls and women with S. haematobium infection will have ectopic parasite eggs deposited in the uterus, cervix, vagina, and vulva, a condition known as female genital schistosomiasis. Schistosomiasis in women has been associated with reproductive and sexual health morbidity, including infertility and prevalent HIV-1. HIV-1 vulnerability in genital schistosomiasis has previously been ascribed to schistosomiasis-associated lesions in the cervix and vagina.

Further details and to join the webinar, click here.

Edit this page